Uithoorn, Netherlands

Eveline Marleen Weerdenburg

USPTO Granted Patents = 6 

 

Average Co-Inventor Count = 8.5

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2022-2025

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Eveline Marleen Weerdenburg: Innovator in Immunology and Bioconjugate Technologies

Introduction

Eveline Marleen Weerdenburg is a notable inventor based in Uithoorn, Netherlands. She has made significant contributions to the fields of immunology and bioconjugate technology, holding a total of five patents that enhance our understanding and application of pharmacological innovations.

Latest Patents

Among Eveline's latest patents are two groundbreaking inventions. The first patent focuses on FimH mutants, specifically polypeptides that comprise a FimH lectin domain with amino acid mutations that render it in a low-affinity conformation for mannose. This invention also describes pharmaceutical compositions containing such polypeptides and methods for stimulating an immune response in individuals in need.

The second patent pertains to methods for producing bioconjugates of O-antigen polysaccharides that are covalently linked to a carrier protein using recombinant host cells. The method leverages specific oligosaccharyl transferase enzymes, which can be variants of PglB oligosaccharyl transferase, enabling the production of customized bioconjugates and innovative vaccination strategies against extra-intestinal pathogenic E. coli (ExPEC).

Career Highlights

Eveline Marleen Weerdenburg has built her career with significant experience in renowned companies such as Janssen Pharmaceuticals Inc. and GlaxoSmithKline Biologicals SA. Her work in these organizations has paved the way for advanced research and development in the pharmaceutical sector, particularly in areas related to vaccine formulation and immune response enhancement.

Collaborations

Throughout her career, Eveline has collaborated with esteemed colleagues, including Jeroen Geurtsen and Pieter Jan Burghout. These collaborations have fostered innovation and propelled advancement in their shared research fields, contributing to successful patent applications and developments in biomedicine.

Conclusion

Eveline Marleen Weerdenburg has established herself as a pioneering inventor in her field, with a focus on immunological advancements and bioconjugate technologies. Her patented innovations not only reflect her expertise but also have the potential to impact public health positively, showcasing the importance of her contributions to the scientific community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…